H3Me Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About H3Me Life Sciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arulsamy Silvester and Ponibass Josephinsheela serve as directors at the Company.
- CIN/LLPIN
U73200TN2011PTC082582
- Company No.
082582
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does H3me Life Sciences Private Limited offer?
H3Me Life Sciences Private Limited offers a wide range of products and services, including Toilet Cleaners, Liquid Toilet Cleaners, Floor Cleaner, Liquid Floor Cleaner.
Who are the key members and board of directors at H3Me Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arulsamy Silvester  | Director | 31-Aug-2022 | Current |
| Ponibass Josephinsheela | Director | 31-Aug-2022 | Current |
Financial Performance of H3Me Life Sciences.
H3Me Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of H3Me Life Sciences?
In 2017, H3Me Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Imagic Technologies LlpActive 12 years 1 monthArulsamy Silvester and Ponibass Josephinsheela are mutual person
- Paisanetwork Consultancy Services LlpActive 5 years 11 months
Arulsamy Silvester and Ponibass Josephinsheela are mutual person
- Biokyc Identity Management LlpActive 5 years 11 months
Arulsamy Silvester and Ponibass Josephinsheela are mutual person
- Filingpoint Corporate Services LlpActive 4 years 10 months
Arulsamy Silvester and Ponibass Josephinsheela are mutual person
- Imaster India Private LimitedActive 14 years 3 days
Arulsamy Silvester and Ponibass Josephinsheela are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at H3Me Life Sciences?
Unlock and access historical data on people associated with H3Me Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H3Me Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H3Me Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
